By Tom Winnifrith | Saturday 8 July 2017
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.
Back in November 2015, Plethora Solutions (PLE) the AIM listed developer of a treatment for premature ejaculation run by offshore based asset stripper Jim Mellon was almost on its uppers, its cash position was critical and its share price had collapsed. Refinancing would have been impossible so it was announced that Regent Pacific, Mellon's Hong Kong based vehicle which already owned 28% of Plethora having chucked good money after bad, was to launch an all share offer worth 12.5p per share. I warned that was too good to be true HERE. And so let's wind forward 20 months...
This area of the ShareProphets.com site is for independent financial commentary. These blogs are provided by independent authors via a common carrier platform and do not represent the opinions of ShareProphets.com. ShareProphets.com does not monitor, approve, endorse or exert editorial control over these articles and does not therefore accept responsibility for or make any warranties in connection with or recommend that you or any third party rely on such information. The information available at ShareProphets.com is for your general information and use and is not intended to address your particular requirements. In particular, the information does not constitute any form of advice or recommendation by ShareProphets.com and is not intended to be relied upon by users in making (or refraining from making) any investment decisions.
Search ShareProphets |
Stock market news |
Recent Comments |